Welcome Customer !

Membership

Help

Suzhou Aitson Pharmaceutical Equipment Co., Ltd
Custom manufacturer

Main Products:

pharmamach>Products

Suzhou Aitson Pharmaceutical Equipment Co., Ltd

  • E-mail

    service@aitesenctm.com

  • Phone

    18118481917

  • Address

    Room 121-123, Building A, No. 188 Suhong East Road, Suzhou Industrial Park

Contact Now

MRNA LNP encapsulation equipment vaccine adjuvant microfluidic control preparation instrument MPE

NegotiableUpdate on 01/18
Model
Nature of the Manufacturer
Producers
Product Category
Place of Origin

Overview

However, from the perspective of practical application development, the advantages of the mRNA LNP encapsulation device vaccine adjuvant microfluidic control preparation instrument MPE can be effectively utilized in the pharmaceutical field, especially in the development of new drugs and quality control of traditional Chinese medicine.

Product Details

  MRNA LNP encapsulation equipment vaccine adjuvant microfluidic control preparation instrument MPE

Adjuvant is a substance added to vaccine formulations that can increase the immunogenicity of vaccine antigens. The term "adjuvant" comes from the Latin word "adjuvante", which means "to help" or "assist". Adjuvant can enhance the innate immune response of the vaccination site, thereby promoting the recognition and presentation of antigens by immune cells and improving the overall immune effect of the vaccine. So far, various adjuvants have been developed, and adjuvants can usually be classified according to their substance composition and physicochemical properties.

With the development of microbiology/immunology, more and more new pathogens and antigens have entered the field of researchers. The mechanisms of action of many new antigens are very different from the past, and the demand for adjuvants is also different. In order to achieve immune effects in newly developed vaccines, people are constantly developing new adjuvants. In addition, with the development of vaccine technology, some existing vaccines are difficult to achieve the expected effects, which also prompts people to develop better and more suitable adjuvants.
But from the perspective of practical application development,MRNA LNP encapsulation equipment vaccine adjuvant microfluidic control preparation instrument MPEThe advantages can be effectively utilized in the pharmaceutical field, especially in the development of new drugs and quality control of traditional Chinese medicine, where there is great potential for growth.
The application prospects of microfluidic technology in new drug development:
1. Natural medicine screening, many techniques in microfluidics such as multi-channel systems, microporous arrays, substrate microfluidics, and concentration gradient methods have been applied in the process of natural medicine screening.
2. The screening of traditional Chinese medicine prescriptions and the application of microfluidic technology for rapid screening and validation of traditional ancient and tested prescriptions in Chinese medicine at the molecular and cellular levels can promote the development of Chinese medicine and protect the research and organization of precious Chinese medicine prescriptions.

3. In drug formulation research, microfluidic chips can release drugs in a scheduled manner by controlling liquid flow, which can be used to create drug controlled release delivery systems. A silicon based microchip has been developed that can release one or more chemical substances through electrical stimulation.